Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

12871 ARTÍCULOS , VIENDO DEL 5176 AL 5190

The genetic nomenclature of recessive cerebellar ataxias

Rossi M, Anheim M, Durr A, Klein C, Koenig M, Synofzik M, Marras C, van de Warrenburg BP; International Parkinson and Movement Disorder Society Task Force on Classification and Nomenclature of Genetic Movement Disorders.

Mov Disord. 2018 Jul;33(7):1056-1076. doi: 10.1002/mds.27415. Epub 2018 May 14.

Clinical Reasoning: Progressive cognitive decline, cerebellar ataxia, recurrent myoclonus, and epilepsy

Xiao F, Fan J, Tan J, Wang XF.

Neurology. 2018 May 15;90(20):e1827-e1831. doi: 10.1212/WNL.0000000000005528.

Purkinje Cell Signaling Deficits in Animal Models of Ataxia

Hoxha E, Balbo I, Miniaci MC, Tempia F.

Front Synaptic Neurosci. 2018 Apr 26;10:6. doi: 10.3389/fnsyn.2018.00006. eCollection 2018.

Trihexyphenidyl for dystonia in cerebral palsy

Harvey AR, Baker LB, Reddihough DS, Scheinberg A, Williams K.

Cochrane Database Syst Rev. 2018 May 15;5(5):CD012430. doi: 10.1002/14651858.CD012430.pub2.

Diabetes mellitus in Friedreich Ataxia: A case series of 19 patients from the German-Austrian diabetes mellitus registry

Pappa A, Häusler MG, Veigel A, Tzamouranis K, Pfeifer MW, Schmidt A, Bökamp M, Haberland H, Wagner S, Brückel J, de Sousa G, Hackl L, Bollow E, Holl RW.

Diabetes Res Clin Pract. 2018 Jul;141:229-236. doi: 10.1016/j.diabres.2018.05.008. Epub 2018 May 26.

Post-acute Rehabilitation for Ataxia Associated with Acute Lithium Toxicity: A Case Report

Nobematsu A, Wakabayashi H, Hanada T, Watanabe N, Tachibana K.

Prog Rehabil Med. 2018 May 16;3:20180010. doi: 10.2490/prm.20180010. eCollection 2018.

Mitochondrial PITRM1 peptidase loss-of-function in childhood cerebellar atrophy

Langer Y, Aran A, Gulsuner S, Abu Libdeh B, Renbaum P, Brunetti D, Teixeira PF, Walsh T, Zeligson S, Ruotolo R, Beeri R, Dweikat I, Shahrour M, Weinberg-Shukron A, Zahdeh F, Baruffini E, Glaser E, King MC, Levy-Lahad E, Zeviani M, Segel R.

J Med Genet. 2018 Sep;55(9):599-606. doi: 10.1136/jmedgenet-2018-105330. Epub 2018 May 15.

Episodic ataxia in a child with senataxin mutation

Sesh S, Radhakrishnan A.

Neurol India. 2018 May-Jun;66(3):842-844. doi: 10.4103/0028-3886.232295.

The expanding spectrum of paroxysmal movement disorders: update from clinical features to therapeutics

McGovern EM, Roze E, Counihan TJ.

Curr Opin Neurol. 2018 Aug;31(4):491-497. doi: 10.1097/WCO.0000000000000576.

Acute transverse myelitis following an opsoclonus-myoclonus syndrome: An unusual presentation

Simon T, Cheuret E, Fiedler L, Mengelle C, Baudou E, Deiva K.

Eur J Paediatr Neurol. 2018 Sep;22(5):878-881. doi: 10.1016/j.ejpn.2018.05.002. Epub 2018 May 8.

Outpatient Interventions That May Enhance the Care of a Patient with Co-existing Moyamoya and Down Syndromes

Lwanga A, Herrera W, Cruz Madrid K, Irungu A.

Cureus. 2018 Mar 16;10(3):e2336. doi: 10.7759/cureus.2336.

A randomized controlled pilot trial of game-based training in individuals with spinocerebellar ataxia type 3

Wang RY, Huang FY, Soong BW, Huang SF, Yang YR.

Sci Rep. 2018 May 18;8(1):7816. doi: 10.1038/s41598-018-26109-w.

Ca(2+) signaling and spinocerebellar ataxia

Hisatsune C, Hamada K, Mikoshiba K.

Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt B):1733-1744. doi: 10.1016/j.bbamcr.2018.05.009. Epub 2018 May 16.

Primary Intracranial Rhabdomyosarcoma in the Cerebellopontine Angle Resected After Preoperative Embolization

Yoshida K, Miwa T, Akiyama T, Nishimoto M, Kamamoto D, Yoshida K.

World Neurosurg. 2018 Aug;116:110-115. doi: 10.1016/j.wneu.2018.05.054. Epub 2018 May 16.

Mad honey: uses, intoxicating/poisoning effects, diagnosis, and treatment

Ullah S, Khan SU, Saleh TA, Fahad S.

RSC Adv. 2018 May 22;8(33):18635-18646. doi: 10.1039/c8ra01924j. eCollection 2018 May 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias